Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

StimTrial Neuromodulation System

K-Number: K243782 · 2025-07-16

Decision Date2025-07-16
Product CodeGZF
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

StimTrial Neuromodulation System is a medical device manufactured by Bioventus, LLC. It received FDA 510(k) clearance on 2025-07-16 under approval number K243782. The device is classified under product code GZF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the StimTrial Neuromodulation System?

StimTrial Neuromodulation System is a medical device that received FDA 510(k) clearance on 2025-07-16. It is manufactured by Bioventus, LLC. The 510(k) number is K243782.

When was StimTrial Neuromodulation System approved by the FDA?

StimTrial Neuromodulation System received FDA 510(k) clearance on 2025-07-16, under approval number K243782.

What company makes StimTrial Neuromodulation System?

StimTrial Neuromodulation System is manufactured by Bioventus, LLC.

What is the FDA product code for StimTrial Neuromodulation System?

The FDA product code for StimTrial Neuromodulation System is GZF.

Related Clinical Trials

Other Devices by Bioventus, LLC

View all 7 devices →

Related Devices (Code: GZF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.